503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
6.17%
Revenue growth 1.25-1.5x CRWD's 4.65%. Bruce Berkowitz would examine if growth advantage is sustainable.
8.46%
Cost growth above 1.5x CRWD's 5.51%. Michael Burry would check for structural cost disadvantages.
5.16%
Gross profit growth 1.25-1.5x CRWD's 4.37%. Bruce Berkowitz would examine sustainability.
-0.95%
Both companies show margin pressure. Martin Whitman would check industry conditions.
4.94%
R&D growth 50-75% of CRWD's 6.66%. Bruce Berkowitz would examine spending effectiveness.
8.97%
G&A growth above 1.5x CRWD's 2.60%. Michael Burry would check for operational inefficiency.
12.65%
Marketing expense growth above 1.5x CRWD's 1.53%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
8.34%
Operating expenses growth above 1.5x CRWD's 3.44%. Michael Burry would check for inefficiency.
8.41%
Total costs growth above 1.5x CRWD's 3.95%. Michael Burry would check for inefficiency.
2.06%
Interest expense growth above 1.5x CRWD's 0.58%. Michael Burry would check for over-leverage.
-7.53%
D&A reduction while CRWD shows 8.01% growth. Joel Greenblatt would examine efficiency.
-3.79%
EBITDA decline while CRWD shows 109.88% growth. Joel Greenblatt would examine position.
-9.38%
EBITDA margin decline while CRWD shows 100.56% growth. Joel Greenblatt would examine position.
3.60%
Operating income growth below 50% of CRWD's 96.91%. Michael Burry would check for structural issues.
-2.42%
Operating margin decline while CRWD shows 88.16% growth. Joel Greenblatt would examine position.
-708.48%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-2.99%
Pre-tax income decline while CRWD shows 6.81% growth. Joel Greenblatt would examine position.
-8.62%
Pre-tax margin decline while CRWD shows 2.06% growth. Joel Greenblatt would examine position.
-6.16%
Tax expense reduction while CRWD shows 42.35% growth. Joel Greenblatt would examine advantage.
-2.27%
Net income decline while CRWD shows 9.79% growth. Joel Greenblatt would examine position.
-7.95%
Net margin decline while CRWD shows 4.91% growth. Joel Greenblatt would examine position.
-2.41%
EPS decline while CRWD shows 5.56% growth. Joel Greenblatt would examine position.
-2.12%
Diluted EPS decline while CRWD shows 11.76% growth. Joel Greenblatt would examine position.
0.03%
Share count reduction exceeding 1.5x CRWD's 0.70%. David Dodd would verify capital allocation.
-0.03%
Diluted share reduction while CRWD shows 0.44% change. Joel Greenblatt would examine strategy.